Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04283-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Omer Qutaiba B Allela und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Alnoor University, Mosul, Iraq. omerqba@proton.me. Hauptthemen laut MEDLINE: Tumor Escape, MicroRNAs, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Abstract (Originalsprache)
Tumor immune evasion is a complex and adaptive mechanism that allows cancer cells to escape immune detection and destruction, contributing to malignancy progression and poor therapeutic outcomes. This review article explores the integral role of the let-7 family of microRNAs (miRNAs) in mediating tumor immune evasion, particularly how these regulators influence the tumor microenvironment (TME) and immune cell functionality. The let-7 family, known for its tumor-suppressive roles, modulates key immune checkpoints, including PD-L1, and pathways linked to immune response regulation, such as the STAT3/SOCS axis, impacts macrophage polarization and modulates immune cell function. Dysregulation of let-7 miRNAs can enhance tumor immune evasion through mechanisms such as downregulating major histocompatibility complex (MHC) expressions, promoting immunosuppressive cell populations, and manipulating metabolic pathways, which together establish an immunosuppressive TME. Conversely, specific let-7 members show potential in restoring anti-tumor immunity by reversing immune suppression and improving T cell responses. By synthesizing current research, this article underscores the dual role of let-7 in both promoting and inhibiting tumor immune evasion, suggesting their potential as therapeutic targets and biomarkers in cancer immunotherapy. Future studies on the context-dependent roles and advanced delivery systems for let-7-targeting therapies are crucial for enhancing immunotherapeutic efficacy and improving patient outcomes across malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Alnoor University, Mosul, Iraq. omerqba@proton.me.
- College of Pharmacy, Ahl Al Bayt University, Kerbala, Iraq.
- Department of Microbiology, Faculty of Science, Marwadi University Research Center, Marwadi University, Rajkot, Gujarat, 360003, India.
- Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
- Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, 140401, India.
- Department of Biomedical, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
Zitieren
APA
Allela, O. Q. B., Al-Hussainy, A. F., Sanghvi, G., Roopashree, R., Kashyap, A., Anand, D. A., Panigrahi, R., Garifulina, L. M., Taher, S. G., Alwan, M., Jawad, M., & Mushtaq, H. (2025). Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04283-9
Vancouver
Allela OQB, Al-Hussainy AF, Sanghvi G, Roopashree R, Kashyap A, Anand DA, et al. Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04283-9
BibTeX
@article{Allela2025,
author = {Allela, Omer Qutaiba B and Al-Hussainy, Ali Fawzi and Sanghvi, Gaurav and Roopashree, R and Kashyap, Aditya and Anand, D Alex and Panigrahi, Rajashree and Garifulina, Lilia Maratovna and Taher, Sada Ghalib and Alwan, Mariem and Jawad, Mahmood and Mushtaq, Hiba},
title = {Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04283-9}
}
EUVIMED